← Companies|Lucid Diagnostics
LU

Lucid Diagnostics

LUCD·NASDAQNew York NYFounded 201880 employees
Micro CapbiotechPublicGI
Platform: EsoGuard Barrett
Market Cap
$0.15B
All Drugs
2
Clinical Trials
4
Failed / Terminated
1
FDA Approved
0
Stock Price & Catalysts (LUCD)
Loading LUCD stock data...
Drug Pipeline (2 programs)
Drug NameCodePhaseTrialsModalityTargetMOAIndications
LUC-2815LUC-2815Phase 12Gene EditingPCSK9PD-L1iGARett
TiramavacamtenLUC-8317Phase 2/32mRNACD47PLK4iDravetMDS
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (3)
2029-12-05
LUC-2815 Interim
Atopic Derm
Interim
2030-09-04
Tiramavacamten Ph3 Readout
ET
Ph3 Readout
2031-06-03
LUC-2815 Interim
Atopic Derm
Interim